期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Improving performance of Cs_(2)AgBiBr_(6)solar cell through constructing gradient energy level with deep-level hole transport material
1
作者 Zi-Yang Xia Wei Zhang +6 位作者 Cheng Chen Hao-Xin wang lin-qin wang Ya-Wei Miao Xing-Dong Ding Li-Cheng Sun Ming Cheng 《Rare Metals》 SCIE EI CAS CSCD 2023年第9期3004-3012,共9页
The valence band offset between Cs_(2)AgBiBr_(6)and hole transport layer(HTL)is approximately 1.00 e V,which results in high energy loss and is identified as one of the bottle necks of Cs_(2)Ag BiBr_(6)perovskite sola... The valence band offset between Cs_(2)AgBiBr_(6)and hole transport layer(HTL)is approximately 1.00 e V,which results in high energy loss and is identified as one of the bottle necks of Cs_(2)Ag BiBr_(6)perovskite solar cell(PSC)for achieving high power conversion efficiency(PCE).To tackle this problem,we propose the optimization of the energy level alignment by designing and synthesizing novel deep-level hole transport materials(HTMs).The sole introduction of deep-level HTMs successfully reduces the valence band offset between Cs_(2)Ag Bi Br_(6)and HTL,but induces the increased valence band offset at HTL/Au interface,limiting the PCE improvement.To further solve the problem and improve the PCE,the gradient energy level arrangement is constructed by combining the newly developed deep-level HTM 6,6’-(3-((9,9-dimethyl-9H-fluoren-3-yl)(4-methoxyphenyl)amino)thiophene-2,5-diyl)bis(N-(9,9-dimethyl-9H-fluoren-2-yl)-N,9-bis(4-methoxyphenyl)-9H-carbazol-3-amine)(TF)with 2,2’,7,7’-tetrakis(N,N’-dipmethoxyphenylamine)-9,9-spirobifluorene(Spiro-OMeTAD).Through optimization,an impressive PCE of 3.50%with remarkably high open-circuit voltage(V_(oc))and fill factor(FF)is achieved,qualifying it among the best pristine Cs_(2)AgBiBr_(6)PSCs. 展开更多
关键词 All-inorganic Cs_(2)AgBiBr_(6)perovskite Stepped energy level structure Energy loss Moisture resistance
原文传递
应对恶性血液肿瘤在新型冠状病毒肺炎疫情中的挑战 被引量:1
2
作者 lin-qin wang Elaine TAN SU YIN +3 位作者 Guo-qing WEI Yong-xian HU Arnon NAGLER He HUANG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2020年第12期921-939,共19页
新型冠状病毒肺炎(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新型传染病.SARS-CoV-2具有极强的传染性,因此在引发流行病后又使其迅速升级为全球大流行,至今仍在部分国家迅速传播.在COVID-19的感染者中,存在肿瘤... 新型冠状病毒肺炎(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新型传染病.SARS-CoV-2具有极强的传染性,因此在引发流行病后又使其迅速升级为全球大流行,至今仍在部分国家迅速传播.在COVID-19的感染者中,存在肿瘤等慢性病或伴有相关合并症的患者预后往往较差.同时,由于恶性血液肿瘤患者长期处于免疫抑制状态,往往感染风险更高且预后更差,所以十分值得我们关注.这篇综述归纳并分析了恶性血液肿瘤患者合并COVID-19后的临床表现.此外,归纳了疫情期间恶性肿瘤的管理策略和感染后的综合干预措施,旨在为临床提供指导. 展开更多
关键词 新型冠状病毒肺炎(COVID-19) 恶性血液肿瘤 免疫抑制 管理策略 治疗方案
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部